Key medicines likely to get costlier soon

Invoking for the first time a provision “in public interest’’, the drug prices regulator NPPA on Friday revised prices of 21 formulations, allowing a one-time increase of 50% from the existing ceiling price. The NPPA’s move is in response to the pharma industry’s requests over the last two years to allow upward revision in prices.

source https://timesofindia.indiatimes.com/india/key-medicines-likely-to-get-costlier-soon/articleshow/72569032.cms